Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients
- 12 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 59 (12), e172-e185
- https://doi.org/10.1093/cid/ciu632
Abstract
Background. Seasonal influenza causes >200 000 annual hospitalizations in the United States. Current antiviral treatment options are limited to oral or inhaled agents. There is an urgent unmet need for intravenous antiviral treatments.Keywords
This publication has 32 references indexed in Scilit:
- Intravenous Peramivir for Treatment of Influenza in Hospitalized PatientsAntiviral Therapy, 2013
- Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus InfectionAntimicrobial Agents and Chemotherapy, 2012
- Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2011
- Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk PatientsAntimicrobial Agents and Chemotherapy, 2011
- Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United StatesClinical Infectious Diseases, 2011
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Drugs in Development for InfluenzaDrugs, 2010
- End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening DiseaseThe Journal of Infectious Diseases, 2010
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus InfectionThe New England Journal of Medicine, 2010
- Influenza-Associated Hospitalizations in the United StatesJama-Journal Of The American Medical Association, 2004